Investors in the commercial space industry are showing increased interest in Rocket Lab USA, Inc. (NASDAQ: RKLB). Due to its focus on innovation and market demands, the company has grown from a small ...

As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...

Rocket Lab is evolving into a vertically integrated space systems leader, with rapid revenue growth and a strong launch cadence fueling its stock surge. The company’s affordable Electron rocket, ...

Rocket Lab is on track for 'a similarly aggressive growth trajectory as SpaceX,' writes KeyBanc Capital Markets analyst Michael Leshock Rocket Lab USA Inc.'s stock initially tumbled in the wake of the ...

Last week, Rocket Lab RKLB scored a satellite contract with the U.S. Space Development Agency, boosting the space stock to a ...

Zai lab's diversified pipeline, strong partnerships, and proven track record of successful drug development make it an attractive investment opportunity in the biotech industry. The recent acceptance ...

U.S. stocks have fallen sharply since the start of 2025. This pullback has created compelling buying opportunities in leading space companies. Rocket Lab USA and Intuitive Machines both offer ...

Rocket Lab reported 69% sales growth in its Q1 earnings report, but still missed analyst targets. Rocket Lab is growing sales nicely, but still isn't profitable. A big defense contract won in late ...

Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the ...

Rocket Lab USA Inc.’s stock initially tumbled in the wake of the company’s fourth-quarter results Thursday, weighed down by weak outlook, although an analyst KeyBanc Capital Markets believes the ...